Elan Overview
- Year Founded
-
1969
- Status
-
Acquired/Merged
- Employees
-
900
- Latest Deal Type
-
M&A
- Financing Rounds
-
8
- Investments
-
24
Elan General Information
Description
Operator of a neuroscience-based biotechnology company. The company is organized into two business units, BioNeurology and Elan Drug Technologies enabling it to develop and manufacture innovative pharmaceuticals for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis and Crohn's disease.
Contact Information
Website
www.elan.comCorporate Office
- Lincoln House, Lincoln Place
- Dublin 2
- Ireland
Corporate Office
- Lincoln House, Lincoln Place
- Dublin 2
- Ireland
Elan Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Elan Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Elan Patents
Elan Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2022121307-A | Content switching device and information processing device | Pending | 08-Feb-2021 | ||
| EP-2968995-B1 | Inhibitors of lrrk2 kinase activity | Inactive | 15-Mar-2013 | ||
| EP-2968995-A1 | Inhibitors of lrrk2 kinase activity | Active | 15-Mar-2013 | ||
| EP-2968995-A4 | Inhibitors of lrrk2 kinase activity | Active | 15-Mar-2013 | ||
| US-20140194428-A1 | Combination treatments for bipolar disorders | Pending | 28-Sep-2012 | A61K31/53 |
Elan Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Elan Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Elan Investments & Acquisitions (24)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Medikabazaar | 29-Oct-2018 | Distributors (Healthcare) | |||
| NewBridge Pharmaceuticals | 29-May-2016 | Drug Delivery | |||
| Proteostasis Therapeutics | 08-Sep-2015 | Drug Discovery | |||
| 910* | 26-Jun-2014 | Media and Information Services (B2B) | |||
| AOP Health | 20-May-2013 | Merger/Acquisition | Distributors (Healthcare) |
Elan Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| AOP Health | Distributors (Healthcare) | Vienna, Austria | 1996 |
| Alpex Pharma | Drug Delivery | Mezzovico, Switzerland |
Elan ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Elan FAQs
-
When was Elan founded?
Elan was founded in 1969.
-
Who is the founder of Elan?
Donald Panoz is the founder of Elan.
-
Where is Elan headquartered?
Elan is headquartered in Dublin, Ireland.
-
What is the size of Elan?
Elan has 900 total employees.
-
What industry is Elan in?
Elan’s primary industry is Biotechnology.
-
Is Elan a private or public company?
Elan is a Private company.
-
What is the current valuation of Elan?
The current valuation of Elan is .
-
What is Elan’s current revenue?
The current revenue for Elan is .
-
How much funding has Elan raised over time?
Elan has raised $2.04B.
-
Who are Elan’s investors?
Atheneum Capital and Vertex Holdings have invested in Elan.
-
When was Elan acquired?
Elan was acquired on 30-Jul-2013.
-
Who acquired Elan?
Elan was acquired by Perrigo Company.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
